Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors-Reference-Cited by-同舟云学术

Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors

Published:2023-06 Issue:6 Volume:4 Page:100524
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Ariyasu Ryo,Kakuto Sho,Miyadera Keiki,Akita Takahiro,Kiritani Ayu,Tsugitomi Ryosuke,Amino Yoshiaki,Uchibori Ken,Kitazono Satoru,Yanagitani Noriko,Nishio Makoto

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Lung cancer in Japan;Horinouchi;J Thorac Oncol,2022

2. Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer;Cochrane Database Syst Rev,2010

3. Addition of bevacizumab to chemotherapy in advanced non-small cell lung cancer: a systematic review and meta-analysis;Lima;PLoS One,2011

4. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol,2010

5. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N Engl J Med,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-cost treatments for advanced lung cancer in Japan (Lung Cancer Study Group of the Japan Clinical Oncology Group);Japanese Journal of Clinical Oncology;2024-08-19

2. Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries;The Lancet Regional Health - Europe;2024-03

3. Role of Epiregulin in Lung Tumorigenesis and Therapeutic Resistance;Cancers;2024-02-07